Page 24 - Product Testing News Today

ABC News Turn on desktop notifications for breaking stories about interest? OffOn Europe starts tests for automated asteroid spotters Scientists say they have switched on a new telescope at the European Southern Observatory as part of an effort to create an automated network for spotting asteroids which might pose a risk to Earth ByThe Associated Press • 2 min read BERLIN -- Scientists said Tuesday they have switched on a new telescope at the European Southern Observatory as part of an effor...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL Erytech Pharma S.A.April 20, 2021 GMT ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL ERYTECH invited by FDA to request a pre-BLA meeting First step in the marketing approval process with the FDA for eryaspase for the treatment of hypersensitive ALL patients based on the positive r...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Arcellx Announces Executive Appointments Arcellx, Inc.April 19, 2021 GMT GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) -- Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new executives to join the company’s leadership team. Dr. Christopher Heery has been named Chief Medical Officer (CMO) where he will have responsibility for clinical, re...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple ... SanofiApril 19, 2021 GMT European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma Approval based on Phase 3 IKEMA study demonstrating Sarclisa added to standard of care carfilzomib and dexamethasone reduced risk of disease progression or death by 47% in pa...

Press release content from Accesswire. The AP news staff was not involved in its creation. CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic April 19, 2021 GMT Review process started with submission of first CVnCoV data package TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 19, 2021 / The CureVac Swiss AG, the Swiss subsidiary of CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company developing a new class of...

Press release content from Accesswire. The AP news staff was not involved in its creation. Abivax Hosting Key Opinion Leader Webinar on ABX464 for the Treatment of Ulcerative Colitis April 19, 2021 GMT The Webinar takes place on Tuesday, April 20, 2021 at 7:30am EDT (1:30pm CEST)PARIS, FRANCE / ACCESSWIRE / April 19, 2021 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company developing novel therapies that ... The Webinar takes place on Tuesday, April 20, 2...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Avadel Presents New Data from its Pivotal REST-ON Phase 3 Trial of FT218, once-nightly sodium ... Avadel Pharmaceuticals plcApril 17, 2021 GMT Secondary endpoint data for once-nightly FT218 further supports previously announced topline data demonstrating clinically meaningful results at 6 g, 7.5 g, and 9 g doses DUBLIN, Ireland, April 17, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AV...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology EhaveApril 16, 2021 GMT MIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to launch brain mapping ketamine clinical trials using Brain Scientific technolog...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Amgen Successfully Completes Acquisition Of Five Prime Therapeutics April 16, 2021 GMT Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/) THOUSAND OAKS, Calif., April 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics (NASDAQ:FPRX), a clinical-stage bi...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. New England Journal of Medicine publishes exploratory study showing signals of positive ... COMPASS Pathfinder Ltd.April 15, 2021 GMT London, UK, April 15, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed a study published in the  New England Journ...